Skip to main content
. 2020 Jun 17;61(6):40. doi: 10.1167/iovs.61.6.40

Table 1.

Data Sources and Subject Numbers for Each Subject Group

Ocular Pathology Data Sources Subjects Excluded Final Total Pathology-Specific Inclusion Criteria
Normal Kwon et al.30 (n = 179) Kwon et al.31 (n = 30) Kwon et al.32 (n = 21) Liu et al.33 (n = 39) Chien et al.34 (n = 27) Age < 18 (n = 1) Incomplete monocular CS (n = 51) 244 Best-corrected visual acuity ≥ 20/30 in each eye; no history of ocular or neurologic disease other than cataract surgery
Cataract Owsley et al.39 (n = 274) Huisingh et al.40 (n = 176) NA 450 Primary diagnosis of cataract in the medical record; no previous cataract surgery in either eye
AMD Giacomelli et al.35 (n = 109) Huisingh et al.40 (n = 123) NA 232 Primary diagnosis of AMD in the medical record40; clinically stable macular changes; no maculopathy due to other causes35
Glaucoma Kwon et al.30 (n = 81) Kwon et al.32 (n = 17) Chien et al.34 (n = 13) Incomplete monocular CS (n = 11) 100 Primary diagnosis of primary open-angle glaucoma in the medical record: (1) glaucoma-specific changes of optic nerve or nerve fiber layer defect; (2) glaucoma-specific visual field defects; (3) no history of other ocular or neurologic disease or surgery that caused visual field loss; (4) not including ocular hypertension or glaucoma suspect
RP Bittner et al.36 (n = 36) Bittner et al.37 (n = 12) Bittner et al.38 (n = 21) Unpublished (n = 25)* Missing age (n = 2) Age < 18 (n = 5) 87 No vision loss due to ocular diseases other than RP; RP further confirmed by electroretinography and optical coherence tomography exams
*

These were subjects in a study by Bittner et al. who completed the VA and CS measures at baseline but did not complete the longer term study that was reported in the previously published paper.36

HHS Vulnerability Disclosure